Waters Corporation (LON:0LTI)
Market Cap | 15.26B |
Revenue (ttm) | 2.30B |
Net Income (ttm) | 507.53M |
Shares Out | n/a |
EPS (ttm) | 8.51 |
PE Ratio | 30.07 |
Forward PE | 26.26 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 20 |
Average Volume | 66 |
Open | 353.05 |
Previous Close | 353.55 |
Day's Range | 349.31 - 353.05 |
52-Week Range | 279.76 - 422.64 |
Beta | 1.12 |
RSI | 52.48 |
Earnings Date | Jul 29, 2025 |
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies soft... [Read more]
Financial Performance
In 2024, Waters's revenue was $2.96 billion, an increase of 0.07% compared to the previous year's $2.96 billion. Earnings were $637.83 million, a decrease of -0.69%.
Financial numbers in USD Financial StatementsNews

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity
News Summary Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security. Integration of Alliance™ iS HPLC System with Empower™ Soft...

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than oth...

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality
News Summary Enables measurements up to 2 days earlier for antibody titers for both clone selection and bioprocess monitoring.1 Provides up to 7x improvements in sensitivity with novel high efficiency...

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
MILFORD, Mass. , May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and c...

Waters Corporation to Present at the Jefferies Global Healthcare Conference
MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

Waters Corp's India business boosted by rush for weight-loss drugs
U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a s...
Waters Corporation: Still A Hold After Q1 Earnings
Waters Corporation raises FY2025 sales growth guidance to 5%-7% amid strong Q1 performance
Waters Corporation (WAT) Q1 2025 Earnings Call Transcript

Waters raises 2025 profit forecast on resilient demand for lab equipment
Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas.

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality co...

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results
Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument grow...

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call
MILFORD, Mass. , April 8, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m.

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC
News Summary Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1 Delivers over threefold improvements in day-to-day reproducibility2 and decreases carryover by up to t...

This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Sustainability Roundtable, Inc. and X-ELIO Announce the Purchase of 172 MW of Purchaser-Caused Solar Energy through SR Inc's Net Zero Consortium for Buyers (NZCB)
BOSTON, March 12, 2025 (GLOBE NEWSWIRE) -- Today, Sustainability Roundtable, Inc. (SR Inc) announced a new aggregated procurement featuring six virtual power purchase agreements (VPPAs) through its Ne...
Waters Corp (WAT) to Present at Leerink Partners Global Healthcare Conference
Waters Corp (WAT) to Present at Leerink Partners Global Healthcare Conference

Waters Corporation to Present at the Leerink Partners Global Healthcare Conference
MILFORD, Mass. , March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D.

Is the Market Bullish or Bearish on Waters?
Waters's (NYSE: WAT) short percent of float has fallen 18.89% since its last report. The company recently reported that it has 1.30 million shares sold short , which is 2.49% of all regular shares th...
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Why Waters Corporation (WAT) Stock is Moving Today
Why Waters Corporation (WAT) Stock is Moving Today
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Waters Corporation 2024 Q4 - Results - Earnings Call Presentation
Waters Corp Reports Q4 Revenue of $873M, Beating Estimates; GAAP EPS of $3.88 Misses Slightly
Waters Corp Reports Q4 Revenue of $873M, Beating Estimates; GAAP EPS of $3.88 Misses Slightly